Home
About
- About Molecure S.A.
- Our Team
R&D
Patients
Investors & media
Careers
Contact
- Whistleblowers

Structure-Guided Discovery of OAT-4828 as Potent, Selective, and Orally Bioavailable USP7 Inhibitor with In Vivo Antileukemic Activity

About us

Molecure is an innovative biotechnology company dedicated to discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases.